Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Colorectal Neoplasms

Free Subscription Articles published in Int J Oncol Retrieve available abstracts of 23 articles: HTML format

Single Articles

February 2022
1. WANG J, Yokoyama Y, Hirose H, Shimomura Y, et al
   Functional assessment of miR1291 in colon cancer cells.
   Int J Oncol. 2022;60.
   PubMed     Abstract available
   
   
   
2. CHEN S, Nishi M, Morine Y, Shimada M, et al
   Epigallocatechin3gallate hinders metabolic coupling to suppress colorectal cancer malignancy through targeting aerobic glycolysis in cancerassociated fibroblasts.
   Int J Oncol. 2022;60.
   PubMed     Abstract available
   
   
   
3. BAHR I, Jaeschke L, Nimptsch K, Janke J, et al
   Obesity, colorectal cancer and MACC1 expression: A possible novel molecular association.
   Int J Oncol. 2022;60.
   PubMed     Abstract available
   
   
   
4. PAN S, Deng Y, Fu J, Zhang Y, et al
   N6methyladenosine upregulates miR181d5p in exosomes derived from cancerassociated fibroblasts to inhibit 5FU sensitivity by targeting NCALD in colorectal cancer.
   Int J Oncol. 2022;60.
   PubMed     Abstract available
   
   
   January 2022
5. LIAO Z, Zhang H, Fan P, Huang Q, et al
   [Corrigendum] High PLK4 expression promotes tumor progression and induces epithelialmesenchymal transition by regulating the Wnt/betacatenin signaling pathway in colorectal cancer.
   Int J Oncol. 2022;60.
   PubMed     Abstract available
   
   
   
6. WATANABE K, Shiga K, Maeda A, Harata S, et al
   Chitinase 3-like 1 secreted from cancer-associated fibroblasts promotes tumor angiogenesis via interleukin-8 secretion in colorectal cancer.
   Int J Oncol. 2022;60.
   PubMed     Abstract available
   
   
   December 2021
7. SHI W, Men L, Pi X, Jiang T, et al
   Shikonin suppresses colon cancer cell growth and exerts synergistic effects by regulating ADAM17 and the IL6/STAT3 signaling pathway.
   Int J Oncol. 2021;59.
   PubMed     Abstract available
   
   
   October 2021
8. SU F, Duan J, Zhu J, Fu H, et al
   Long noncoding RNA nuclear paraspeckle assembly transcript 1 regulates ionizing radiationinduced pyroptosis via microRNA448/gasdermin E in colorectal cancer cells.
   Int J Oncol. 2021;59.
   PubMed     Abstract available
   
   
   September 2021
9. YAO J, Wang C, Dong X, Zhang Y, et al
   lncRNA SNHG22 sponges miR1283p to promote the progression of colorectal cancer by upregulating E2F3.
   Int J Oncol. 2021;59.
   PubMed     Abstract available
   
   
   
10. CHOUCAIR K, Radford M, Bansal A, Park R, et al
    Advances in immune therapies for the treatment of microsatellite instabilityhigh/deficient mismatch repair metastatic colorectal cancer (Review).
    Int J Oncol. 2021;59.
    PubMed     Abstract available
    
    
    August 2021
11. ASHIZAWA N, Shimizu H, Shoda K, Furuya S, et al
    NADPH oxidase 5 has a crucial role in cellular motility of colon cancer cells.
    Int J Oncol. 2021;59.
    PubMed     Abstract available
    
    
    July 2021
12. SHEN X, Ye Z, Wu W, Zhao K, et al
    lncRNA NEAT1 facilitates the progression of colorectal cancer via the KDM5A/Cul4A and Wnt signaling pathway.
    Int J Oncol. 2021;59.
    PubMed     Abstract available
    
    
    June 2021
13. YANG Q, Wang X, Tang C, Chen X, et al
    [Retracted] H19 promotes the migration and invasion of colon cancer by sponging miR138 to upregulate the expression of HMGA1.
    Int J Oncol. 2021;58.
    PubMed     Abstract available
    
    
    
14. LIAO Z, Zhang H, Fan P, Huang Q, et al
    [Corrigendum] High PLK4 expression promotes tumor progression and induces epithelialmesenchymal transition by regulating the Wnt/betacatenin signaling pathway in colorectal cancer.
    Int J Oncol. 2021;58.
    PubMed     Abstract available
    
    
    May 2021
15. ABDULLA MH, Agarwal D, Singh JK, Traiki TB, et al
    Association of the microbiome with colorectal cancer development (Review).
    Int J Oncol. 2021;58.
    PubMed     Abstract available
    
    
    March 2021
16. HA THI HT, Duong HQ, Hong S
    Emerging roles of noncoding RNAs in the response of rectal cancer to radiotherapy (Review).
    Int J Oncol. 2021;58:344-358.
    PubMed     Abstract available
    
    
    February 2021
17. ANDO S, Fukamachi K, Yoshimoto E, Matsumoto H, et al
    Palmitoyl piperidinopiperidine, a novel derivative of 10hydroxy2decenoic acid, as a potent and selective anticancer agent against human colon carcinoma cell lines.
    Int J Oncol. 2021;58:251-265.
    PubMed     Abstract available
    
    
    December 2020
18. OH S, Song H, Freeman WM, Shin S, et al
    Cooperation between ETS transcription factor ETV1 and histone demethylase JMJD1A in colorectal cancer.
    Int J Oncol. 2020;57:1319-1332.
    PubMed     Abstract available
    
    
    
19. PARK M, Kwon J, Shin HJ, Moon SM, et al
    Butyrate enhances the efficacy of radiotherapy via FOXO3A in colorectal cancer patientderived organoids.
    Int J Oncol. 2020;57:1307-1318.
    PubMed     Abstract available
    
    
    November 2020
20. WANG J, Liang D, Zhang XP, He CF, et al
    Novel PI3K/Akt/mTOR signaling inhibitor, W922, prevents colorectal cancer growth via the regulation of autophagy.
    Int J Oncol. 2020 Nov 23. doi: 10.3892/ijo.2020.5151.
    PubMed     Abstract available
    
    
    September 2020
21. QIAN J, Garg A, Li F, Shen Q, et al
    lncRNA LUNAR1 accelerates colorectal cancer progression by targeting the miR4953p/MYCBP axis.
    Int J Oncol. 2020 Sep 25. doi: 10.3892/ijo.2020.5128.
    PubMed     Abstract available
    
    
    
22. FENG J, Xiao T, Lu SS, Hung XP, et al
    ANXA1derived peptides suppress gastric and colon cancer cell growth by targeting EphA2 degradation.
    Int J Oncol. 2020 Sep 7. doi: 10.3892/ijo.2020.5119.
    PubMed     Abstract available
    
    
    August 2020
23. KIM SL, La MT, Shin MW, Kim SW, et al
    A novel HDAC1 inhibitor, CBUD1001, exerts anticancer effects by modulating the apoptosis and EMT of colorectal cancer cells.
    Int J Oncol. 2020 Aug 10. doi: 10.3892/ijo.2020.5109.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: